The evolution of coronary stents.

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• Percutaneous coronary intervention (PCI) marks 40 years of evolution from experimental procedures to a global standard.
• Technological advancements and clinical trials have driven the transition from plain old balloon angioplasty (POBA) to drug-eluting stents (DES).

Observation:

• Early PCI methods like POBA faced challenges such as acute vessel closure.
• Bare metal stents (BMS) addressed restenosis but introduced issues like stent thrombosis with bioabsorbable platforms.
• The development progressed through first-generation DES, second-generation DES, and absorbable platforms.

Findings:

• The evolution of PCI, including POBA, BMS, and various DES generations, has addressed and overcome significant clinical setbacks.
• Modern drug-eluting stents represent a safe and effective standard of care in interventional cardiology.
• Landmark trials have been pivotal in reshaping contemporary PCI practices.

Implications:

• Future directions in PCI may involve innovative technologies like Prohealing Endothelial Progenitor Cell Capture Stents.
• The continuous innovation in PCI technology and materials has dramatically improved patient outcomes.
• Understanding this historical progression is crucial for appreciating the current safety and efficacy of interventional cardiology procedures.